GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Revenue

Aker BioMarine ASA (OSL:AKBM) Revenue : kr3,677 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Revenue?

Aker BioMarine ASA's revenue for the three months ended in Mar. 2024 was kr831 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr3,677 Mil. Aker BioMarine ASA's Revenue per Share for the three months ended in Mar. 2024 was kr9.48. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr38.30.

During the past 12 months, the average Revenue per Share Growth Rate of Aker BioMarine ASA was 14.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 56.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Aker BioMarine ASA's highest 3-Year average Revenue per Share Growth Rate was 398.60% per year. The lowest was -45.00% per year. And the median was 7.80% per year.


Aker BioMarine ASA Revenue Historical Data

The historical data trend for Aker BioMarine ASA's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Revenue Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,221.44 2,512.77 2,353.95 2,738.76 3,537.21

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 727.78 956.56 1,014.56 874.55 830.93

Competitive Comparison of Aker BioMarine ASA's Revenue

For the Packaged Foods subindustry, Aker BioMarine ASA's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA's Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Revenue distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Revenue falls into.



Aker BioMarine ASA Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,677 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA  (OSL:AKBM) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Aker BioMarine ASA Revenue Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines